Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer

We examined a large dataset of female metastatic breast cancers (MBCs) profiled with comprehensive genomic profiling (CGP) to identify the prevalence and distribution of immunotherapy responsiveness‐associated biomarkers. DNA was extracted from 3831 consecutive MBCs: 1237 (ER(pos)/HER2 (neg)), 1953...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Sivapiragasam, Abirami, Ashok Kumar, Prashanth, Sokol, Ethan S., Albacker, Lee A., Killian, Jonathan K., Ramkissoon, Shakti H., Huang, Richard S. P., Severson, Eric A., Brown, Charlotte A., Danziger, Natalie, McGregor, Kimberly, Ross, Jeffrey S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7826457/
https://ncbi.nlm.nih.gov/pubmed/33314633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3550
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars